You are here

Maternal, Fetal, and Neonatal Imatinib Levels With Treatment of Chronic Myeloid Leukemia in Pregnancy

Article type:

Original publication date: 
Saturday, May 13, 2017

Burwick, Richard M. MD, MPH; Kuo, Kelly MD; Brewer, Diana PA; Druker, Brian J. MD

BACKGROUND: Pregnant women with chronic myeloid leukemia (CML) can be treated effectively with the tyrosine-kinase inhibitor imatinib, but data regarding fetal and neonatal exposure and safety are limited.


CASE: We present a patient with newly diagnosed CML in early pregnancy. Leukapheresis and interferon-α were initiated in the second trimester with limited benefit.